<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Kelyniam Global Inc — News on 6ix</title>
<link>https://6ix.com/company/kelyniam-global-inc</link>
<description>Latest news and press releases for Kelyniam Global Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Mon, 16 Mar 2026 04:01:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/kelyniam-global-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68358e5d78dffbe2df101302.webp</url>
<title>Kelyniam Global Inc</title>
<link>https://6ix.com/company/kelyniam-global-inc</link>
</image>
<item>
<title>Kelyniam Global Reports 2025 Financial Results</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-reports-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-reports-2025-financial-results</guid>
<pubDate>Mon, 16 Mar 2026 04:01:00 GMT</pubDate>
<description>Kelyniam Global Reports 2025 Financial Results.</description>
</item>
<item>
<title>Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-secures-exclusive-us-license-for-evoniks-vestakeepr-fusion-biomaterial-in-cranial-implants</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-secures-exclusive-us-license-for-evoniks-vestakeepr-fusion-biomaterial-in-cranial-implants</guid>
<pubDate>Thu, 13 Nov 2025 17:47:00 GMT</pubDate>
<description>Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants.</description>
</item>
<item>
<title>Kelyniam Global Announces Q3 2025 Financial Results</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-announces-q3-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-announces-q3-2025-financial-results</guid>
<pubDate>Mon, 10 Nov 2025 20:55:00 GMT</pubDate>
<description>Kelyniam Global Announces Q3 2025 Financial Results.</description>
</item>
<item>
<title>Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-renews-licensing-agreement-with-finceramica-unlocking-access-to-valuable-pipeline-products</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-renews-licensing-agreement-with-finceramica-unlocking-access-to-valuable-pipeline-products</guid>
<pubDate>Fri, 07 Nov 2025 00:09:00 GMT</pubDate>
<description>CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licensing agreement with Finceramica Faenza S.p.A., an innovative Italian biomaterials company. The three-year extension strengthens the longstanding partnership, granting Kelyniam expanded access to Finceramica's advanced product portfolio, including SINTlife, a next-generation fully resorbable syntheti</description>
</item>
<item>
<title>Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion™ BCP-PEEK Implant</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-inc-receives-fda-clearance-for-innovative-fusiontm-bcp-peek-implant</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-inc-receives-fda-clearance-for-innovative-fusiontm-bcp-peek-implant</guid>
<pubDate>Thu, 18 Sep 2025 15:23:00 GMT</pubDate>
<description>Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion™ BCP-PEEK Implant.</description>
</item>
<item>
<title>Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/life-sciences-virtual-investor-forum-presentations-now-available-for-online-viewing-2</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/life-sciences-virtual-investor-forum-presentations-now-available-for-online-viewing-2</guid>
<pubDate>Thu, 18 Sep 2025 12:35:00 GMT</pubDate>
<description>Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing.</description>
</item>
<item>
<title>Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-inc-to-present-at-the-life-sciences-virtual-investor-forum-september-18th</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-inc-to-present-at-the-life-sciences-virtual-investor-forum-september-18th</guid>
<pubDate>Tue, 16 Sep 2025 12:35:00 GMT</pubDate>
<description>Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th.</description>
</item>
<item>
<title>Commitment to Investor</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/commitment-to-investor</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/commitment-to-investor</guid>
<pubDate>Mon, 08 Sep 2025 04:01:00 GMT</pubDate>
<description>Commitment to Investor.</description>
</item>
<item>
<title>Kelyniam Global Announces Q2 2025 Financial Results</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-announces-q2-2025-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-announces-q2-2025-financial-results</guid>
<pubDate>Mon, 11 Aug 2025 15:16:00 GMT</pubDate>
<description>Kelyniam Global Announces Q2 2025 Financial Results.</description>
</item>
<item>
<title>Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/osteopore-limited-asxosx-elevates-partnership-with-kelyniam-for-the-us-craniofacial-market</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/osteopore-limited-asxosx-elevates-partnership-with-kelyniam-for-the-us-craniofacial-market</guid>
<pubDate>Mon, 12 May 2025 05:35:00 GMT</pubDate>
<description>Osteopore Limited (ASX:OSX) Elevates Partnership with Kelyniam for the U.S. Craniofacial Market.</description>
</item>
<item>
<title>Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-announces-q1-2025-financial-results-and-strategic-partnership</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-announces-q1-2025-financial-results-and-strategic-partnership</guid>
<pubDate>Mon, 12 May 2025 04:00:00 GMT</pubDate>
<description>Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership.</description>
</item>
<item>
<title>KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-achieves-record-revenue-and-profitability-for-2024</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-achieves-record-revenue-and-profitability-for-2024</guid>
<pubDate>Mon, 17 Mar 2025 04:00:36 GMT</pubDate>
<description>KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024.</description>
</item>
<item>
<title>Kelyniam Corporate Update</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-corporate-update</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-corporate-update</guid>
<pubDate>Tue, 21 Jan 2025 05:00:42 GMT</pubDate>
<description>Kelyniam Corporate Update.</description>
</item>
<item>
<title>Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-inc-klyg-announces-private-investment-to-public-entity-pipe-closure-of-securities-offering</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-inc-klyg-announces-private-investment-to-public-entity-pipe-closure-of-securities-offering</guid>
<pubDate>Mon, 16 Dec 2024 05:01:43 GMT</pubDate>
<description>Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering.</description>
</item>
<item>
<title>Kelyniam Global Releases Q3 Financials, Strong Performance Continues</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-q3-financials-strong-performance-continues</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-q3-financials-strong-performance-continues</guid>
<pubDate>Mon, 11 Nov 2024 05:01:43 GMT</pubDate>
<description>Kelyniam Global Releases Q3 Financials, Strong Performance Continues.</description>
</item>
<item>
<title>Kelyniam Global Releases Strong Q2 Financials</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-strong-q2-financials</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-strong-q2-financials</guid>
<pubDate>Mon, 12 Aug 2024 04:02:47 GMT</pubDate>
<description>Kelyniam Global Releases Strong Q2 Financials.</description>
</item>
<item>
<title>Kelyniam Global Releases Q1 Financials</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-q1-financials</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-q1-financials</guid>
<pubDate>Mon, 13 May 2024 22:04:00 GMT</pubDate>
<description>Kelyniam Global Releases Q1 Financials.</description>
</item>
<item>
<title>NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/neos-cranial-looptm-receives-fda-clearance-for-customizedbonetm-use</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/neos-cranial-looptm-receives-fda-clearance-for-customizedbonetm-use</guid>
<pubDate>Tue, 02 Apr 2024 04:01:01 GMT</pubDate>
<description>NEOS Cranial LOOP™ Receives FDA Clearance for CustomizedBone™ Use.</description>
</item>
<item>
<title>Strong Fourth Quarter Powers 2023 Kelyniam Financials</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/strong-fourth-quarter-powers-2023-kelyniam-financials</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/strong-fourth-quarter-powers-2023-kelyniam-financials</guid>
<pubDate>Sun, 17 Mar 2024 04:00:43 GMT</pubDate>
<description>Strong Fourth Quarter Powers 2023 Kelyniam Financials.</description>
</item>
<item>
<title>Kelyniam Global Releases 3rd Quarter 2023 Financials</title>
<link>https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-3rd-quarter-2023-financials</link>
<guid isPermaLink="true">https://6ix.com/company/kelyniam-global-inc/news/kelyniam-global-releases-3rd-quarter-2023-financials</guid>
<pubDate>Thu, 21 Dec 2023 15:21:28 GMT</pubDate>
<description>Kelyniam Global Releases 3rd Quarter 2023 Financials.</description>
</item>
</channel>
</rss>